Trial intelligence / Profile preview

Metformin for Antipsychotic-induced Dyslipidemia

NCT01778244Phase 4Completed

Sponsor
Central South University
Start
Nov 2008
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of metformin in dyslipidemia, sponsored by Central South University. Started Nov 2008; status: completed.

02

Drugs

metformin
03

Conditions

dyslipidemia

Beyond the preview

Go deeper on NCT01778244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01778244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call